Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Small Molecule
      Early Development
    • Small Molecule
      Late Development
    • Route Scouting and Selection
    • High Potency APIs
    • Solid State & Preformulation
    • Analytical Science
    • Separation Science
    • Oligonucleotides
    • Peptides
    • Bioscience
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

CatSci publishes an article on Chemistry World

Mar 13th 2018
News
CatSci publishes an article on Chemistry World

13 Mar 2018        

Biosensors, wearables, and virtual biotech…

Our CEO Dr Ross Burn shares his thoughts on the future of pharma in Royal Society of Chemistry’s Chemistry World magazine.

Back to News

Related Articles

CatSci Ltd Wins SMART Capital Equipment Grant to Open Second Oligonucleotides Lab to Drive Innovation in RNA Therapeutics
News

CatSci Ltd Wins SMART Capital Equipment Grant to Open Second Oligonucleo...

Oct 8th 2024
CatSci and Reach Industries Win Innovate UK Grant to Accelerate Development of Oligonucleotides
News

CatSci and Reach Industries Win Innovate UK Grant to Accelerate Developm...

Aug 5th 2024
CatSci Achieves 2024 Bronze EcoVadis Sustainability Rating
News

CatSci Achieves 2024 Bronze EcoVadis Sustainability Rating

Jul 17th 2024

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • CatSci Corporate and Social Responsibility (CSR) Policy
  • Sustainability Report 2024

What we do

  • Small Molecule Late Development
  • Small Molecule Early Development
  • Route Scouting and Selection
  • Analytical Science
  • High Potency APIs
  • Solid State and Preformulation
  • Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need. 

© 2025 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.